BSECompany Update21 Aug 2026 · 21 Aug 2026, 02:32 pm

Intimation regarding appointment of Mr. Sunil Sharma and resignation of Ms. Seema Salvi as HOD injectable

Mercury Laboratories Ltd · 538964

✦ AI SummaryMgmt Change

Mercury Laboratories Ltd has announced the appointment of Mr. Sunil Sharma as Head of the Department (Injectable Production) and the resignation of Ms. Seema Salvi from the same position, effective August 21, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Change in Management

Attachments (1)

📄

fb7e0d06-4a9c-430d-9c25-17c4a70d0192.pdf

pdf

Download →
View document text
Date: 21/08/2026 Corporate Relations Department BSE Limited Phiroze Jeejeebhoy Towers, 25th Floor, Dalal Street, Mumbai – 400 001 Scrip Code: 538964 Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for appointment and resignation of Senior Management Personnel (SMP). Dear Sir/Madam, Pursuant to Regulation 30 read with Para A(7) of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we would like to inform you that 1. Mr. Sunil Sharma has been appointed as Head of the Department (Dept.-Injectable Production) of the Company with effect from August 21, 2026. 2. Ms. Seema Salvi, Head of the Department (Dept.-Injectable Production) designated as Senior Management Personnel (SMP) of the Company has tendered her resignation for better opportunities and career advancement. It is further informed that there is no other material reason for the resignation other than the reason mentioned in Annexure-A. The said resignation letter is enclosed herewith as Annexure-B. The details of changes as required under Regulation 30 of SEBI (LODR) Regulations, 2015 read with Section V-A of Chapter V of Master Circular issued vide circular no. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 and SEBI/HO/CFD/CFD-PoD- 1/P/CIR/2023/123 dated July 13, 2023 is enclosed herewith as Annexure-A. You are requested to take the above information on record. Thanking You! Yours faithfully, For Mercury Laboratories Limited Rajendra Shah Managing Director DIN 00257253 Encl: As above Annexure-A Sr. Details of Information Information of such events No required to be provided Mr. Sunil Sharma Ms. Seema Salvi 1. Reason for change viz. Mr. Sunil Sharma appointed Ms. Seema Salvi, HOD- appointment, resignation, as Head of the Department Injectable Production reappointment, (Dept.-Injectable Production) designated as Senior removal, death Management Personnel (SMP) or otherwise of the Company has tendered her resignation for better opportunities and career advancement. There is no other material reason for the resignation other than the reason mentioned in resignation letter. 2. Date of Date of appointment: August Date of Cessation : August 21, Appointment/Cessation & 21, 2026 2026 (Closure of business term of appointment Term of appointment: Full hours) time employment. 3. Brief profile (in case of Mr. Sunil Sharma, age about Not applicable appointment) 45 years, holds Bachelor degree in Pharmacy (B.Pharm). He has rich experience of more than 19 years in the field of Injection Production. Earlier he was associated with Flagship Biotech International Pvt Ltd, Bharat Parentals Limited, Intas Pharmaceuticals Limited and Sun Pharma. 4. Disclosure of relationships Not applicable Not applicable between directors (in case of appointment of a director). Date: 21/08/2026 Managing Director Mercury Laboratories Limited Sub: Notice of Resignation from MercuryL aboratoriesL imited Respected Sir, With reference to above captioned subject, I hereby tender my resignation from the position of Head of the Department (Injectable Production) of the Company for better opportunities and career advancement Therefore, I kindly request the management to accept my resignation and relieve me from my duties with the effect from the closure of business hours on 21/08/2026 It was pleasure and privilege to be part of Mercury Laboratories Limited. I deeply grateful for the opportunities guidance and support received throughout my tenure. I would like to thank all board members and my colleagues for their guidance, support and cooperation during my tenure with the Company. Kindly acknowledge the receipt of this Resignation letter With~s, Ms. Seema Salvi